Roivant Sciences Ltd Asset Turnover Ratio (ROIV), as of fourth quarter 2025, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Roivant Sciences Ltd   (NASDAQ: ROIV)
 

Roivant Sciences Ltd Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

According to the latest Balance sheet Mar 31 2026, Roivant Sciences Ltd has not recorded any assets.
Visit Roivant Sciences Ltd Balance sheet

Within sector 193 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2025 compared to the preceding quarter from 0 to 3681.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ROIV Asset Turnover Ratio (Mar 31 2026)
IV. Quarter		 (Dec 31 2025)
III. Quarter		 (Sep 30 2025)
II. Quarter		 (Jun 30 2025)
I. Quarter		 (Mar 31 2025)
IV. Quarter
Y / Y Asset Change 5 % -3.48 % -13.52 % -18.7 % -21.55 %
Y / Y Revenue Change -66.71 % -77.83 % -64.89 % -96.06 % -73.83 %
Asset Turnover Ratio (TTM) 0 0 0 0 0.01
ROIV's Total Ranking # 3681 # 0 # 0 # 0 # 0
Seq. Asset Change 9.25 % 3.22 % 0.6 % -7.44 % 0.43 %
Seq. Revenue Change 26.06 % 27.24 % -27.6 % -71.33 % -16.06 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 194
Healthcare Sector # 550
Overall Market # 3681

Asset Turnover Ratio Statistics
High Average Low
0.05 0.02 0
  (Mar 31 2026)




ROIV Company Profile • Back to ROIV Efficiency Comparisons • Compare ROIV Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Mar 31 2026 Assets at quarter ending Mar 31 2026
Prokidney Corp 0.00 $ 0.889  Millions$ 338.025  Millions
Pavmed Inc 0.00 $ 0.107  Millions$ 41.548  Millions
IMPACT BIOMEDICAL INC. 0.00 $ 0.039  Millions$ 17.940  Millions
Cardio Diagnostics Holdings Inc 0.00 $ 0.017  Millions$ 9.128  Millions
Crispr Therapeutics Ag 0.00 $ 4.103  Millions$ 2,316.521  Millions
Sharps Technology Inc 0.00 $ 0.397  Millions$ 227.781  Millions
Roivant Sciences Ltd 0.00 $ 8.260  Millions$ 5,257.314  Millions
Ainos Inc 0.00 $ 0.018  Millions$ 22.389  Millions
Aditxt Inc 0.00 $ 0.014  Millions$ 18.729  Millions
Quoin Pharmaceuticals Ltd 0.00 $ 0.009  Millions$ 12.855  Millions
Sera Prognostics Inc 0.00 $ 0.057  Millions$ 103.857  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.